VRCA compared with ANIK: revenue, margins and what each company keeps, and the suppliers and customers both name

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

ANIKAnika Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VRCAVerrica Pharmaceuticals Inc.

ANIKAnika Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closesMethod ›

Moved together

VRCAwithANIK

No shared trading history for VRCA and ANIK.

Shared co-movers: not yet measured (VRCA).

VRCA, solidANIK, hatchedr = correlationBar = r to r 0.75Source: daily closes

VRCAVerrica Pharmaceuticals Inc.

3.20▼−0.31%· post 3.27· delayed

Mkt cap$55.1MRevenue$6MQ2 FY26Revenue$36MFY25

ANIKAnika Therapeutics, Inc.

19.33▼−0.42%· post 19.33· delayed

After hoursNov 3 '26delayed

Mkt cap$259.8MRevenue$33MQ2 FY26Revenue$113MFY25

Compare

After hoursNov 3 '26delayed

VRCAVerrica Pharmaceuticals Inc.

ANIKAnika Therapeutics, Inc.

3.20▼−0.31%post 3.27delayed

Price

19.33▼−0.42%post 19.33delayed

$55.1M

Mkt cap

$259.8M

Q2 FY26$6M

Revenue

$33MQ2 FY26

FY25$36M

Revenue

$113MFY25

VRCA3.20▼−0.31%vsANIK19.33▼−0.42%After hoursNov 3 '26delayed